Erich Allen Riehl, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 401 S Ballenger Hwy, Attn Surgical Services, Flint, MI 48532 Phone: 810-342-4917 |
Alexis Marie Mccann, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1085 S Linden Rd Ste 150, Flint, MI 48532 Phone: 810-262-2100 |
Celeena Kawar, Physician Assistant Medicare: Medicare Enrolled Practice Location: 303 E Kearsley St, Flint, MI 48502 Phone: 301-385-0356 |
Ms. Michele L. Beckett, PAC Physician Assistant - Surgical Medicare: Accepting Medicare Assignments Practice Location: 1 Hurley Plz, Flint, MI 48503 Phone: 810-257-9000 Fax: 810-262-9509 |
Mr. Joseph Michael Jacot, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 5020 W Bristol Rd, Flint, MI 48507 Phone: 810-732-1620 Fax: 810-732-8559 |
Mr. Benjamin James Busuito, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 225 E 5th St Ste 300, Flint, MI 48502 Phone: 810-406-4913 |
Mr. Joseph Galard Iii, PHYSICIAN ASSISTANT Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 2700 Robert T Longway Blvd, Suite B, Flint, MI 48503 Phone: 810-235-2004 Fax: 810-235-2841 |
Christopher Joseph Gard, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 2265 S Linden Rd, Flint, MI 48532 Phone: 810-720-8700 |
News Archive
Patients with type-2 diabetes and cardiovascular disease can safely take the antihyperglycemic drug sitagliptin without an increased risk of cardiovascular complications - even if they have a history of heart failure - a new analysis of the TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) study shows.
SunLink Health Systems, Inc. today announced earnings from continuing operations for its fourth fiscal quarter ended June 30, 2009 of $850,000, or $0.11 per fully diluted share, compared to earnings from continuing operations of $579,000, or $0.07 per fully diluted share, for the quarter ended June 30, 2009.
The U.S. Food and Drug Administration's mission to protect and promote public health by ensuring the safety of the nation's food supply, as well as the safety and efficacy of medical products, has always relied on a rigorous analysis of the scientific data available and a strong commitment to safety.
Ascension Orthopedics, Inc., a leader in orthopedic extremity implants, announces the international market launch of the PyroTITAN™ Humeral Resurfacing Arthroplasty System at the American Academy of Orthopaedic Surgeons Annual Conference in New Orleans, LA, March 9-13, 2010. Designed to meet the unique soft tissue biocompatibility requirements of the shoulder joint, the PyroTITAN humeral resurfacing implant is the first commercially-available, human shoulder arthroplasty prosthesis made of PyroCarbon.
High levels of arsenic in rice have been shown to be associated with elevated genetic damage in humans, a new study has found.
› Verified 3 days ago